By combining expertise in clinical biomarker development, bioinformatics and paper based microfluidics the consortium will develop a novel liver damage assay.
Over the course of 2 years the consortium filled with young and ambitious SMEs will develop a test that can quickly and easily identify early signs of liver damage in patients resulting in reduction of treatment costs and the optimisation of treatment.
Conditions resulting from damaged liver are a huge societal burden resulting in increase of costs for the healthcare, therefore robust and quick screening testing for liver damage would provide a viable solution to the problem.
The grant proposal has been ranked in the top 10 of applications within the region. The total associated project budget is €1.000.000. And the province of Zuid Holland will be awarding a subsidy of €349.996 towards the project for the realisation of its goals and deliverables.